Platelet cancer cell interplay as a new therapeutic target
K Morris, B Schnoor, AL Papa - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
The interaction between circulating tumor cells and platelets is a key factor in cancer
metastasis. These interactions, driven by a variety of receptors, support circulating tumor …
metastasis. These interactions, driven by a variety of receptors, support circulating tumor …
The non-hemostatic aspects of transfused platelets
C Sut, S Tariket, C Aubron, C Aloui… - Frontiers in …, 2018 - frontiersin.org
Platelets transfusion is a safe process, but during or after the process, the recipient may
experience an adverse reaction and occasionally a serious adverse reaction (SAR). In this …
experience an adverse reaction and occasionally a serious adverse reaction (SAR). In this …
[HTML][HTML] Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia
N Terrault, YC Chen, N Izumi, Z Kayali, P Mitrut… - Gastroenterology, 2018 - Elsevier
Background & Aims Patients with thrombocytopenia and chronic liver disease (CLD) may
require platelet transfusions before scheduled procedures to decrease risk of bleeding. We …
require platelet transfusions before scheduled procedures to decrease risk of bleeding. We …
A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP‐I trial (Editorial, p. 2759)
BACKGROUND Cryopreservation extends platelet (PLT) shelf life from 5 to 7 days to 2 to 4
years. However, only 73 patients have been transfused cryopreserved PLTs in published …
years. However, only 73 patients have been transfused cryopreserved PLTs in published …
Responsive and reliable injured-oriented blood supply chain for disaster relief: a real case study
S Cheraghi, SM Hosseini-Motlagh - Annals of operations research, 2020 - Springer
In disaster relief, one major concern is to have an efficient network to supply and distribute
critical items such as blood to the affected areas. Based on a real case study, a tailored …
critical items such as blood to the affected areas. Based on a real case study, a tailored …
[HTML][HTML] Minimum platelet count threshold before invasive procedures in cirrhosis: evolution of the guidelines
M Biolato, F Vitale, T Galasso… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Cirrhotic patients with severe thrombocytopenia are at increased risk of bleeding during
invasive procedures. The need for preprocedural prophylaxis aimed at reducing the risk of …
invasive procedures. The need for preprocedural prophylaxis aimed at reducing the risk of …
On the Way to in vitro Platelet Production
C Strassel, C Gachet, F Lanza - Frontiers in medicine, 2018 - frontiersin.org
The severely decreased platelet counts (10–30. 103 platelets/μL) frequently observed in
patients undergoing chemotherapy, radiation treatment, or organ transplantation are …
patients undergoing chemotherapy, radiation treatment, or organ transplantation are …
Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports
Acute hemolytic transfusion reaction following ABO-incompatible platelet transfusion: two
case reports An ideal platelet transfusion should provide ABO identical platelet concentrate …
case reports An ideal platelet transfusion should provide ABO identical platelet concentrate …
A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia
Objective: Investigate globally, current treatment patterns, benefit-risk assessments,
humanistic, societal and economic burden of platelet transfusion (PT). Methods: Publications …
humanistic, societal and economic burden of platelet transfusion (PT). Methods: Publications …
[PDF][PDF] 17 例RhD 血型不相合血小板输注的回顾性分析与策略
陈伟， 王珊， 李慧君， 邱进， 王儒彬， 李强， 李菲 - 临床血液学杂志, 2023 - lcxy.whuhzzs.com
目的: 通过回顾性分析RhD 血型不相合血小板输注的患者, 总结RhD 不相合血小板输注的经验和
应对策略. 方法: 利用医院六级电子病历和临床输血管理系统, 获取2014 至2021 年血型为RhD …
应对策略. 方法: 利用医院六级电子病历和临床输血管理系统, 获取2014 至2021 年血型为RhD …